Fatma Yekta ÜRKMEZ KORKMAZ, İmran HASANOĞLU, Gül Ruhsar YILMAZ, Mehmet Akın TAŞYARAN, Rahmet GÜNER, Fatma ESER, Ziya Cibali AÇIKGÖZ

Risk factors for rectal colonization of carbapenem-resistant Enterobacteriaceae in a tertiary care hospital: a case-control study from Turkey

Background/aim: This study aimed to evaluate the risk factors of patients colonized with carbapenem-resistant Enterobacteriaceae(CRE).Materials and methods: The study was conducted between January 2010 and March 2016. The colonized group consisted of patientswho had a CRE strain in their rectal swab cultures, whereas patients with negative rectal surveillance cultures for CRE who wereconcurrently hospitalized in the same units with the colonized group patients were included in the control group.Results: The number of patients in the colonized and the control group was 71 and 120, respectively. Both groups were evaluated fordemographic and healthcare-associated characteristics. Isolated microorganisms in rectal surveillance cultures for CRE were Klebsiellapneumoniae (75.5%), Escherichia coli (15.5%), Enterobacter cloacae (4.2%), Klebsiella oxytoca (1.4%), and Klebsiella terrigena (1.4%).The isolates were resistant to imipenem, meropenem, and ertapenem (52.1%, 73.2%, and 100%, respectively). In multivariate analysis,presence of decubitus, colistin usage, glycopeptide usage, and fluoroquinolone usage were found to be independent risk factors for CREcolonization. There was no significant difference between the two groups with regards to mortality (P = 0.070).Conclusion: These results are in agreement with the current literature. The findings of this study could be useful for improvement ofinfection control strategies related to CRE.

PDF

___

1. Sanchez GV, Master RN, Clark RB, Fyyaz M, Duvvuri P, Ekta G, Bordon J. Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010. Emerg Infect Dis 2013; 19: 133-136.
2. Senbayrak Akcay S, Inan A, Cevan S, Ozaydın AN, Cobanoglu N, Ozyurek SC, Aksaray S. Gram-negative bacilli causing infections in an intensive care unit of a 44 tertiary care hospital in Istanbul, Turkey. J Infect Dev Ctries 2014; 8: 597-604.
3. Centers for Disease Control. Facility Guidance for Control of Carbapenem Resistant Enterobacteriaceae (CRE) November 2015 Update. Atlanta, GA, USA: CDC; 2015.
4. Hayden MK, Lin MY, Lolans K, Weiner S, Blom D, Moore NM, Fogg L, Henry D, Lyles R, Thurlow C et al. Centers for Disease Control and Prevention Epicenters Program. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 2015; 60: 1153- 1161.
5. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, GalMor O, Maor Y, Rahav G. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012; 18: 54-60.
6. Bhargava A, Hayakawa K, Silverman E, Haider S, Alluri KC, Datla S, Diviti S, Kuchipudi V, Muppavarapu KS, Lephart PR et al. Risk factors for colonization due to carbapenemresistant Enterobacteriaceae among patients exposed to longterm acute care and acute care facilities. Infect Control Hosp Epidemiol. 2014; 35: 398-405.
7. Akturk H, Sutcu M, Somer A, Aydın D, Cihan R, Ozdemir A, Coban A, Ince Z, Citak A, Salman N. Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensivecare units: risk factors for progression to infection. Braz J Infect Dis 2016; 20: 134-140.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 22nd Informational Supplement Document M100-S22. Wayne, PA, USA: CLSI; 2012.
9. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 2014; 42: e61-64.
10. Swaminathan M, Sharma S, Poliansky Blash S, Patel G, Banach DB, Phillips M, LaBombardi V, Anderson KF, Kitchel B, Srinivasan A et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013; 34: 809-817.
11. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, Schlaeffer F, Sherf M, Peled N. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem resistant K. pneumoniae. Am J Infect Control 2012; 40: 421-425.
12. Çilli FF, Arda B, Uyan A, Kayın M, Dikiş D, Korkmaz N, Küçükler ND, Kepeli N, Ulusoy B, Akşit Barik Ş et al. What is the rectal colonization rate of carbapenem-resistant Enterobacteriaceae (CRE)-infected patients? What is the decolonization rate of CRE-colonized patients in the hospital? Turk J Med Sci 2017; 47: 1053-1054.
13. Dickstein Y, Edelman R, Dror T, Hussein K, Bar-Lavie Y, Paul M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect 2016; 94: 54-59.
14. Ling ML, Tee YM, Tan SG, Amin IM, How KB, Tan KY, Lee LC. Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control 2015; 4: 26.
15. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, Paiva JA, Cakar N, Ma X, Eggimann P et al. Characteristics and determinants of outcome of hospitalacquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012; 38: 1930-1945.
16. Eser F, Yılmaz GR, Güner R, Koçak Tufan Z, Güven T, Açıkgöz ZC, Taşyaran MA. Carbapenem resistant Enterobacteriaceae infections: risk factors. Akd Med J 2018; 2: 144-151.
17. Torres-Gonzalez P, Cervera-Hernandez ME, NiembroOrtega MD, Leal-Vega F, Cruz-Hervert LP, García-García L, Galindo-Fraga A, Martinez-Gamboa A, Bobadilla-Del Valle M, Sifuentes-Osornio J et al. Factors associated to prevalence and incidence of carbapenem-resistant Enterobacteriaceae fecal carriage: a cohort study in a Mexican tertiary care hospital. PLoS One. 2015; 10: e0139883.
18. Bogan C, Kaye KS, Chopra T, Hayakawa K, Pogue JM, Lephart PR, Bheemreddy S, Lazarovitch T, Zaidenstein R, Perez F et al. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control 2014; 42: 612- 620.
19. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52: 1028-1033.
20. Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Asymptomatic rectal carriage of bla (KPC) producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013; 19: 451-456.
21. Bektas A, Guducuoglu H, Gursoy NC, Berktaş M, Gultepe BS, Parlak M, Otlu B, Tekerekoglu MS. Investigation of extended spectrum beta-lactamase (ESBL) genes in ESBL-producing Escherichia coli and Klebsiella pneumoniae strains. FLORA 2018; 23: 116-123.
22. Zarakolu P, Eser OK, Aladag E, Al-Zahrani IA, Day KM, Atmaca O, Boral B, Cakir B, Perry JD, Akova M. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis 2016; 85: 466-470.
23. Huang TD, Poirel L, Bogaerts P, Berhin C, Nordmann P, Glupczynski Y. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. J Antimicrob Chemother 2014; 69: 445-450.